Jasper Therapeutics, Inc.Insider Ownership
|
|
Current Insider Ownership
You need to login to see this data
| Roche Finance Ltd | 10% Owner | Voting Common Stock | Jan 25, 2023 | 4,549,606 | 27.99 | 3,821,669 |
| Venkataraman Balaji | 10% Owner | Common Stock, par value $0.0001 per share | Feb 8, 2024 | 1,188,500 | 7.31 | 998,340 |
| Martell Ron | President and CEO | Common Stock Warrant (right to buy)Performance Restricted Stock UnitsStock Option (right to buy)Voting Common Stock | Sep 22, 2025Jun 10, 2024Jan 2, 2026Sep 22, 2025 | 41,00020,0002,301,83174,118 | 0.250.1214.160.46 | 34,44016,8001,933,53862,259 |
Insider Trading Trends
Insider Transactions
Voluntary Buys vs Sells
You need to login to see this data
Historical Insider Trading (3-Years)
10b5-1
You need to login to see this data
| Mahal Jeetinder Singh | Voting Common Stock | No | No | Grant | ACQUIRE A | 1.35 | +500,000 | 675,000 | 500,000 | Feb 6, 2026 | |
| Martell Ron | Voting Common Stock | No | No | Grant | ACQUIRE A | 1.84 | +234,000 | 430,560 | 234,000 | Jan 2, 2026 | |
| Cross Herb | Voting Common Stock | No | No | Grant | ACQUIRE A | 1.84 | +90,000 | 165,600 | 90,000 | Jan 2, 2026 | |